Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling
Abstract
Share and Cite
Nobili, A.; Pane, M.; Skvortsova, M.; Ben Salem, M.; Morgenthaler, S.; Jamieson, E.; Di Stefano, M.; Bathrellou, E.; Mamalaki, E.; Ramos-Garcia, V.; et al. Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling. Microorganisms 2024, 12, 931. https://doi.org/10.3390/microorganisms12050931
Nobili A, Pane M, Skvortsova M, Ben Salem M, Morgenthaler S, Jamieson E, Di Stefano M, Bathrellou E, Mamalaki E, Ramos-Garcia V, et al. Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling. Microorganisms. 2024; 12(5):931. https://doi.org/10.3390/microorganisms12050931
Chicago/Turabian StyleNobili, Angelica, Marco Pane, Mariya Skvortsova, Meryam Ben Salem, Stephan Morgenthaler, Emily Jamieson, Marina Di Stefano, Eirini Bathrellou, Eirini Mamalaki, Victoria Ramos-Garcia, and et al. 2024. "Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling" Microorganisms 12, no. 5: 931. https://doi.org/10.3390/microorganisms12050931
APA StyleNobili, A., Pane, M., Skvortsova, M., Ben Salem, M., Morgenthaler, S., Jamieson, E., Di Stefano, M., Bathrellou, E., Mamalaki, E., Ramos-Garcia, V., Kuligowski, J., Vasileiadis, M., Georgiadis, P., Falcone, M., & Refinetti, P. (2024). Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling. Microorganisms, 12(5), 931. https://doi.org/10.3390/microorganisms12050931

